Action Point Financial Planning’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-122
Closed -$1.96K – 2287
2026
Q2
$1.96K Buy
+122
New +$2.02K ﹤0.01% 2272

Other funds holding TAK

Action Point Financial Planning's TAK Position: Q3 2026 in Review

Action Point Financial Planning sold out of Takeda Pharmaceutical (TAK) in Q3 2026, closing a stake of 122 shares — an estimated $1.96K sold.

Action Point Financial Planning first reported a position in TAK in Q2 2026 and held it in 1 quarter. The position peaked at $1.96K in Q2 2026. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Action Point Financial Planning reported no remaining Takeda Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 122 Takeda Pharmaceutical shares in Q3 2026, an estimated $1.96K.
  • Action Point Financial Planning first reported a position in Takeda Pharmaceutical in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Takeda Pharmaceutical position peaked at $1.96K in Q2 2026.
  • 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.